跳至主要内容
临床试验/CTRI/2025/07/091489
CTRI/2025/07/091489尚未招募2/3 期

Randomized open controlled clinical study to evaluate the efficacy of Shigrumula kwath in the management of Mutrashmari W.S.R. to Urolithiasis.

Dr Prerana Prakash Kaknale1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年8月21日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
Shigrumula Kwath is effective in the management of Mutrashmari.

研究概览

简要总结

This is Randomized open controlled clinical study to evaluate the efficacy of Shigrumula kwath in the management of Mutrashmri with special reference to Urolithiasis. This study will be done in the Shalyatantra OPD of Yashwant Ayurvedic Medical college, Kodoli Tal-Panhala, Dist-Kolhapur.

This study will be carried out by comparing two groups.

First Group (Trial Group) will be given Shigrumula kwath 40 ml BID before meal and Second Group (Control Group) will be given Cap. Renali 500 mg BID after meal. The result will be observed, and the conclusion will be drawn on the basis of observed values.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient with clinical features and USG showing ureteric, kidney, bladder calculus of size less than 6 mm.
  • The patient will be selected irrespective of gender, religion, occupation, marital status.
  • Patient with controlled DM and HTN.

排除标准

  • Patient of haematuria like bleeding disorders, glomerulonephritis, Nephropathy, drug induced haematuria etc.
  • K/C/O Uterine, Cervical, Vaginal, Urethral malignancy or any suspected malignancy, active genital herpes.
  • Patients having other disorders like STDs, Gout.
  • Pregnant and lactating women.

结局指标

主要结局

Shigrumula Kwath is effective in the management of Mutrashmari.

时间窗: Initial assessment on 0th day. | Follow up on 10th, 20th, 30th day. | Final assessment on 30th day.

次要结局

  • 1) To study the effect of shigrumula kwath to reduce the sign and(symptoms of mutrashmari.)

研究者

发起方
Dr Prerana Prakash Kaknale
申办方类型
Other [Self ]
责任方
Principal Investigator
主要研究者

Dr Prerana Prakash Kaknale

Yashwant Ayurvedic medical College, Kodoli, Tal- Panhala, Dist- Kolhapur

研究点 (1)

Loading locations...

相似试验